Alport syndrome-diffuse leiomyomatosis (AS-DL, OMIM: 308940) is a rare variant of the X-linked Alport syndrome that shows overgrowth of visceral smooth muscles in the gastrointestinal, respiratory and female reproductive tracts in addition to renal symptoms. AS-DL results from deletions that encompass the 5′ ends of the COL4A5 and COL4A6 genes, but deletion breakpoints between COL4A5 and COL4A6 have been determined in only four cases. Here, we characterize deletion breakpoints in five AS-DL patients and show a contiguous COL4A6/COL4A5 deletion in each case. We also demonstrate that eight out of nine deletion alleles involved sequences homologous between COL4A5 and COL4A6. Most breakpoints took place in recognizable transposed elements, including long and short interspersed repeats, DNA transposons and long-terminal repeat retrotransposons. Because deletions involved the bidirectional promoter region in each case, we suggest that the occurrence of leiomyomatosis in AS-DL requires inactivation of both genes. Altogether, our study highlights the importance of homologous recombination involving multiple transposed elements for the development of this continuous gene syndrome and other atypical loss-of-function phenotypes.
INTRODUCTION
Alport syndrome (AS) is the most common hereditary nephropathy, characterized by a progressive renal failure, sensorineural deafness and ocular abnormalities. The most common X-linked form of this disease (XLAS, OMIM: 301050) results from mutations in the COL4A5 gene, which encodes the α5 chain of type IV collagen. 1 Alport syndromediffuse leiomyomatosis (AS-DL, OMIM: 308940) occurs as a rare variant of XLAS that shows overgrowth of visceral smooth muscles in the gastrointestinal, respiratory and female reproductive tracts, in addition to renal symptoms. [1] [2] [3] COL4A5 is located on the long arm of the X chromosome (Xq22) and is head-to-head with the COL4A6 gene. The COL4A6 gene encodes the α6 chain of type IV collagen, which is mainly expressed in heart, human esophagus, aorta and bladder smooth muscle basement membrane. [3] [4] [5] AS-DL patients exhibit contiguous gene deletions at the COL4A5-COL4A6 locus. 5 Sixteen AS-DL patients reported so far have been found to have a deletion that encompassed the 5′ end of the COL4A5 and COL4A6 genes, and included the bidirectional promoter (the Human Genome Mutation Database). The COL4A6 deletion breakpoints have been consistently found within intron 2, whereas the COL4A5 breakpoints usually occur in intron 1. 6 However, the breakpoints were characterized at a single-nucleotide level only in four cases. [6] [7] [8] [9] 
PATIENTS AND METHODS
In our laboratory, we conduct a comprehensive molecular diagnostics of inherited kidney diseases, including AS. So far, 415 suspected AS patients underwent molecular genetic tests, five of them with clinical signs of leiomyomatosis. The pedigrees of the five cases are shown in Supplementary Figure 1 .
Genomic DNA was isolated from peripheral blood leukocytes. Screening of contiguous gene deletions was performed with the multiplex ligation probe amplification (MLPA) using the SALSA P191/192 Alport MLPA assay (MRC-Holland, Amsterdam, the Netherlands). 2, 10, 11 Long-range PCR amplification and direct sequencing of COL4A5 and COL4A6 was conducted to characterize the deletion breakpoints. The human reference sequence of NG_011977.1 and NG_012059.2 for COL4A5 and COL4A6 was used, respectively.
To detect a large heterozygous deletion in Case 2, we conducted a semiquantitative PCR amplification using capillary electrophoresis. 12, 13 RESULTS The MLPA analysis of five patients with AS-DL revealed hetero-or hemizygous deletions in each case (Supplementary Figure 2 ). This analysis was followed by long-range PCRs and direct sequencing to identify each breakpoint ( MLPA analysis of maternal samples of Cases 1, 3 and 4 failed to detect any deletion, suggesting that, unlike Cases 2 and 5, these are sporadic cases.
DISCUSSION
This work has more than doubled the number of sequencecharacterized COL4A5 and COL4A6 breakpoints in AS-DL. Although eight out of nine cases had homologous sequences at the deletion breakpoints, only two cases (c3 and p2) showed relatively long homologous sequences in the L1 family of long interspersed elements, consistent with a well-known L1-mediated recombination mechanism. 16 Almost a half of the human genome is occupied by recognizable TEs, with L1 occupying~17%. 17 TEs have been shown to provide a source of new exons, genes and regulatory sequences, dramatically influencing evolutionary history, exon-intron structure, speciation and regulation of gene expression. TEs facilitate non-allelic homologous recombination events leading to inherited diseases, 14 including AS-DL (Figure 2 ). 8 As compared to c3 and p2, Cases c1, c4, c5, p1 and p3 revealed shorter homologous sequences indicative of the same mechanism. The number of breakpoints in TEs 13/18 (72%) appears to be higher than expected since TEs represent only 40% and 62% of the genomic sequences of COL4A6 and COL4A5, respectively suggesting that TEs might have some roles for causing recombination in this disease.
All deletion breakpoints characterized at the single-nucleotide level in COL4A6 took place in intron 2. [6] [7] [8] [9] Recently, an AS-DL case was identified with a deletion extending into COL4A6 beyond this intron, 2 but the precise breakpoint was not characterized. On the COL4A5 side, the deletion breakpoint usually maps to intron 1; however, some cases, including two of ours (c3 and c4), showed breakpoints in intron 36 and intron 4, respectively. Recently, Sa et al. reported an AS-DL case with a COL4A5-only gene deletion, which encompassed exons 1 − 51 but did not include the common promoter region or exon 1 of COL4A6. 18 This report may still be compatible with the requirement for inactivation of both genes in AS-DL, as first proposed by Recent studies in yeasts revealed that deletion of many genes were associated with altered mRNA levels of the neighboring genes. 19 These studies are particularly relevant for bidirectional promoters which generate products of two adjacent, often related genes in stoichiometric quantities, ensuring their co-expression in the same or similar biological pathway.
In conclusion, we have more than doubled the number of large contiguous deletions in AS-DL characterized at the single-nucleotide level. Our results show that most deletions were mediated by transposons via homologous recombination events and support the original proposal 5 that inactivation of both genes is required for the development of leiomyomas in AS-DL.
